Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by made2laston Aug 28, 2017 11:33am

145 Views

Post# 26628199

RE:Wow - Gilead to buy Kite for $11.9 billion

Hi SizzlinSteaks;

Back on April 5, 2017, bencro wrote a fine post about company valuations, including KITE.

Read: https://stockhouse.com/companies/bullboard/v.tlt/theralase-technologies-inc?postid=26081731

Bencro, if you are reading this post, perhaps you can be so kind as to update your post to show the board how the advances in the clinic translated for KITE valuation, and how those same valuation metrics would translate to Theralase future valuation.

Thanks;

made2last

Bullboard Posts

Investors eye Australian gold mining projects amid promising developments